Syntaxin
www.syntaxin.com
Innovative medicines derived from botulinum toxin

Development of innovative drugs for acromegaly, pain and post-operative immobilization on the basis of a proprietary protein engineering platform dedicated to botulinum toxin.

News :


Syntaxin And Ipsen Enter Into...
10/21/2011

Syntaxin and Ipsen enter into a strategic agreement to develop novel botulinum-toxin...
Read more
PDF File